AnalystsSriharsha PappuSriharsha Pappu's Stock Forecasts
AnalystsSriharsha Pappu
Sectors:
Industries:
Analyst Ranking
Bottom 18%
#3792 out of 4563 analysts
Average Return
-4.81%
Win Rate
55%6 out of 11
Risk vs Reward
Poor
Good
Sriharsha Pappu's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Zymergen IncZY | +67.27% | $8.25 | $2.70 | 2021-08-03 - 2022-08-03 | Sell |
Linde PLCLIN | +29.17% | $253.34 | $327.25 | 2020-11-24 - 2021-11-24 | Strong Buy |
Lyondellbasell Industries NvLYB | +21.23% | $80.89 | $98.06 | 2017-06-25 - 2017-10-10 | Strong Buy |
Linde PLCLIN | +11.69% | $298.32 | $333.18 | 2021-06-02 - 2022-06-02 | Strong Buy |
Linde PLCLIN | +6.16% | $302.86 | $321.52 | 2022-02-17 - 2023-02-17 | Strong Buy |
Sriharsha Pappu Analyst Color
Get additional color on Sriharsha Pappu's coverage of popular stocks
Sriharsha Pappu's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Linde PLCLIN | 4 | Strong Buy | $382.00 | N/A | Maintains | 2 years ago |
Lyondellbasell Industries NvLYB | 5 | Strong Buy | $112.00 | N/A | Upgrades | 2 years ago |
Ginkgo Bioworks Holdings IncDNA | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 3 years ago |
Zymergen IncZY | 2 | Sell | $8.00 | N/A | Downgrades | 3 years ago |
Air Products & Chemicals IncAPD | 3 | Hold | $269.00 | N/A | Maintains | 3 years ago |
Amyris IncAMRSQ | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Dupont De Nemours IncDD | 1 | Hold | $74.00 | N/A | Downgrades | 3 years ago |
Dow IncDOW | 1 | Sell | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.